LENZ THERAPEUTICS, INC. (LENZ) Free cash flow 2020–2025
LENZ THERAPEUTICS, INC. (LENZ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.0MFY2025 · since FY2020: -$10.3M → -$70.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.0M | -16.9% |
| FY2024 | -$59.9M | +0.9% |
| FY2023 | -$60.4M | +36.1% |
| FY2022 | -$94.6M | -61.4% |
| FY2021 | -$58.6M | -470.7% |
| FY2020 | -$10.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LENZ financial trends
LENZ RevenueLENZ Net incomeLENZ Net marginLENZ Gross profitLENZ Gross marginLENZ Operating incomeLENZ Operating marginLENZ Operating cash flowLENZ Capital expendituresLENZ Return on equityLENZ Stock buybacksLENZ Dividends paidLENZ Total assetsLENZ Total liabilitiesLENZ Shareholders’ equityLENZ overview →